Give insulin via inhalation.. The possibility of a sharp drop in blood sugar as a result of using this type of insulin

Was approved to give insulin by inhalation for the first time from the Food and Drug Administration (FDA). Still this type of insulin focus of research at the present time as an alternative to insulin injections. And some of them, if they are inhaled in the form of powder or powder called Xciobara (Exubera) Or give it using my mouth sprays   In the form of spray liquid is absorbed through the mucous membrane the Ojuntin profile, tongue and throat and called Aoralen (Oralin).
  In this way insulin is filled in the form of a dry powder in an inhalation device that allows the entry of insulin in a cavity in the end piece is inserted into the patient's mouth and through which inhaled insulin powder. The maximum effect of insulin-like Xaobera fast-acting and duration of stay in the body like a normal short-acting insulin.
And patients who use insulin by inhalation can not dispense with the College for insulin injections, but this method of giving insulin may be helpful when used before eating. And also can give him with antihypertensive medications for sugar which is given by mouth in patients with type II diabetes, or in emergency situations when there is a need to give insulin quickly. It must be used with long-acting insulin like Algelargen in patients with type I diabetes.
And give insulin in the form of a spray may be a better impact on the level of cholesterol in the blood than that given in the form of inhalation is not known exactly why this is so.
The side effects of this type of insulin similar to other types of insulin. And the patient must note the possibility of a sharp drop in blood sugar as a result of using this type of insulin. In addition, in view of the fact that the absorption of the drug through the lung, there is fear of potential impact on lung function. In fact there was a decrease in lung function when use Alxaobera but soon returned to normal after stopping treatment. Since this product is still new, it is advisable to conduct examination of lung function of the patient prior to the use of insulin by inhalation. If the values ​​of FEV1 Less than 70% should not use this medication. This needs to be re test again after six months of using the drug. If there was a decrease in lung function فيوقف medication use.
And also should not use Alxaobera in:
** Sick smokers regularly or intermittently.
* Patients who need very small doses of insulin.
* Patients who suffer from diseases of the lung.
* Children and pregnant women.
However this drug may be a good option for some diabetics.
Previous Post Next Post

Contact Form